Mosterd, Charlotte M
Nephroprotective effects of GLP-1 receptor agonists: where do we stand? [electronic resource]
- Journal of nephrology Oct 2020
- 965-975 p. digital
Publication Type: Journal Article; Review
1724-6059
10.1007/s40620-020-00738-9 doi
Cardiovascular Diseases--drug therapy
Diabetes Mellitus, Type 2--complications
Diabetic Nephropathies--drug therapy
Glucagon-Like Peptide-1 Receptor
Humans
Hypoglycemic Agents--adverse effects
Pharmaceutical Preparations